113 related articles for article (PubMed ID: 34534735)
1. Performance of enhancement on brain MRI for identifying HER2 overexpression in breast cancer brain metastases.
Young JR; Ressler JA; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Eur J Radiol; 2021 Nov; 144():109948. PubMed ID: 34534735
[TBL] [Abstract][Full Text] [Related]
2. Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases.
Young JR; Ressler JA; Shiroishi MS; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Acad Radiol; 2023 Sep; 30(9):1816-1822. PubMed ID: 36549990
[TBL] [Abstract][Full Text] [Related]
3. Association of lesion contour and lesion composition on MR with HER2 status in breast cancer brain metastases.
Young JR; Ressler JA; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Magn Reson Imaging; 2023 Feb; 96():60-66. PubMed ID: 36423795
[TBL] [Abstract][Full Text] [Related]
4. Association Between
Young JR; Ressler JA; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Nucl Med Mol Imaging; 2024 May; 58(3):113-119. PubMed ID: 38633284
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Contrast-Enhanced MRI Evaluation of Pathologic Complete Response in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer After HER2-Targeted Therapy.
Heacock L; Lewin A; Ayoola A; Moccaldi M; Babb JS; Kim SG; Moy L
Acad Radiol; 2020 May; 27(5):e87-e93. PubMed ID: 31444111
[TBL] [Abstract][Full Text] [Related]
7. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
Wang C; Wei W; Santiago L; Whitman G; Dogan B
Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
[TBL] [Abstract][Full Text] [Related]
8. Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
van der Velden BHM; Sutton EJ; Carbonaro LA; Pijnappel RM; Morris EA; Gilhuijs KGA
Eur Radiol; 2018 Nov; 28(11):4705-4716. PubMed ID: 29736850
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
[TBL] [Abstract][Full Text] [Related]
10. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
Agner SC; Rosen MA; Englander S; Tomaszewski JE; Feldman MD; Zhang P; Mies C; Schnall MD; Madabhushi A
Radiology; 2014 Jul; 272(1):91-9. PubMed ID: 24620909
[TBL] [Abstract][Full Text] [Related]
11. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
12. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
14. Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?
van der Velden BHM; Bismeijer T; Canisius S; Loo CE; Lips EH; Wesseling J; Viergever MA; Wessels LFA; Gilhuijs KGA
Eur J Radiol; 2019 Dec; 121():108705. PubMed ID: 31655316
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
Youk JH; Son EJ; Chung J; Kim JA; Kim EK
Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
[TBL] [Abstract][Full Text] [Related]
17. Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?
Koh J; Park AY; Ko KH; Jung HK
Eur Radiol; 2019 Dec; 29(12):7000-7008. PubMed ID: 31187220
[TBL] [Abstract][Full Text] [Related]
18. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
[TBL] [Abstract][Full Text] [Related]
19. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study.
Kim ES; Cho N; Kim SY; Kwon BR; Yi A; Ha SM; Lee SH; Chang JM; Moon WK
Korean J Radiol; 2021 Mar; 22(3):297-307. PubMed ID: 33289355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
